Company: SCYX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001140361-25-016641
Chunk: 38

Company: SCYNEXIS INC
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 38
---
 terms of Mr. Macleod’s employment as our Chief Financial Officer. Pursuant to the agreement, Mr. Macleod was entitled to receive an annual salary of $435,000 (which has been subsequently increased to $452,400 for 2024 and $470,496 for 2025) and is eligible to receive an annual performance bonus of up to 40% of his base salary and certain equity awards. Mr. Macleod is entitled to certain severance payments and benefits under his employment agreement, subject to executing a release and settlement agreement in a form acceptable to us, as further described below.

26

TABLE OF CONTENTS

Employment agreement with Mr. Sukenick. We entered into an employment agreement with Mr. Sukenick in November 2017 setting forth the terms of Mr. Sukenick’s employment as our General Counsel. Pursuant to the agreement, Mr. Sukenick was entitled to receive an annual salary of $320,000 (which has been subsequently increased to $445,120 for 2024 and $462,925 for 2025) and is eligible to receive an annual performance bonus of up to 40% of his base salary and certain equity awards. Mr. Sukenick is entitled to certain severance payments and benefits under his employment agreement, subject to executing a release and settlement agreement in a form acceptable to us, as further described below. Termination and Change in Control Severance Benefits Severance Agreements with Dr. Angulo, Mr. Macleod and Mr. Sukenick Dr. Angulo, Mr. Macleod and Mr. Sukenick are entitled to certain severance payments and benefits under their respective employment agreements, subject to the applicable executive officer executing a release and settlement agreement in a form acceptable to us. In the event of a termination without “just cause” by us or an executive officer’s resignation for “good reason” at any time other than during the twelve-month period following a “change in control” (or, for Dr. Angulo, during the ninety (90) day period prior to a “change in control”), the executive officer is eligible to receive the following payments and benefits:

| • | in the case of Dr. Angulo, a cash amount equal to 18 months of his then current base salary, which will be paid out in a lump sum on the 60thday following his termination date, and in the case of each of Mr. Macleod and Mr. Sukenick